8871 related articles for article (PubMed ID: 1389476)
1. Downmodulation of c-myc expression by interferon gamma and tumour necrosis factor alpha precedes growth arrest in human melanoma cells.
Osanto S; Jansen R; Vloemans M
Eur J Cancer; 1992; 28A(10):1622-7. PubMed ID: 1389476
[TBL] [Abstract][Full Text] [Related]
2. Cytokine-mediated modulation of HLA-class II, ICAM-1, LFA-3 and tumor-associated antigen profile of melanoma cells. Comparison with anti-proliferative activity by rIL1-beta, rTNF-alpha, rIFN-gamma, rIL4 and their combinations.
Mortarini R; Belli F; Parmiani G; Anichini A
Int J Cancer; 1990 Feb; 45(2):334-41. PubMed ID: 1689276
[TBL] [Abstract][Full Text] [Related]
3. Effect of verapamil on the class I major histocompatibility complex antigen expression in K562 chronic myelogenous leukemia cells treated with recombinant human interferon-gamma.
Takemura Y; Koide Y; Miyachi H; Shibata T; Sekiguchi S
Cancer Lett; 1992 Aug; 65(2):99-106. PubMed ID: 1511424
[TBL] [Abstract][Full Text] [Related]
4. Influence of tumor necrosis factor-alpha on the modulation by interferon-gamma of HLA class II molecules in human thyroid cells and its effect on interferon-gamma binding.
Buscema M; Todd I; Deuss U; Hammond L; Mirakian R; Pujol-Borrell R; Bottazzo GF
J Clin Endocrinol Metab; 1989 Aug; 69(2):433-9. PubMed ID: 2502555
[TBL] [Abstract][Full Text] [Related]
5. [Inhibition of proto-oncogene c-myc expression with recombinant human tumor necrosis factor-alpha and interferon-gamma in HL-60 cell lines and acute myelocytic leukemic fresh cells].
Yuan YC; Shen SY
Zhonghua Nei Ke Za Zhi; 1994 May; 33(5):302-5. PubMed ID: 7835139
[TBL] [Abstract][Full Text] [Related]
6. Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) on human renal cell carcinoma.
Hillman GG; Puri RK; Kukuruga MA; Pontes JE; Haas GP
Clin Exp Immunol; 1994 Jun; 96(3):476-83. PubMed ID: 8004818
[TBL] [Abstract][Full Text] [Related]
7. Synergistic enhancement of class I major histocompatibility complex antigen expression in K562 cells induced by recombinant human interferon-gamma and tumor necrosis factor in combination.
Takemura Y; Koide Y; Kawabata M; Kitajima S; Ohba C; Suzuki H; Sekiguchi S
Exp Hematol; 1989 Aug; 17(7):795-9. PubMed ID: 2502422
[TBL] [Abstract][Full Text] [Related]
8. Interferon gamma and tumour necrosis factor alpha induce a synergistic antiproliferative response in human Ewing's sarcoma cells in vitro.
van Valen F; Winkelmann W; Burdach S; Göbel U; Jürgens H
J Cancer Res Clin Oncol; 1993; 119(10):615-21. PubMed ID: 8335680
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of c-myc expression by tumor necrosis factor-alpha in combination with transforming growth factor-beta or interferon-gamma with concomitant inhibition of proliferation in human cell lines.
Hori M; Kamijo R; Takeda K; Nagumo M
J Interferon Res; 1994 Apr; 14(2):49-55. PubMed ID: 8077765
[TBL] [Abstract][Full Text] [Related]
10. Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor.
Hoon DS; Banez M; Okun E; Morton DL; Irie RF
Cancer Res; 1991 Apr; 51(8):2002-8. PubMed ID: 1901239
[TBL] [Abstract][Full Text] [Related]
11. Tumour necrosis factor and interferon are selectively cytostatic in vitro for hormone-dependent and hormone-independent human breast cancer cells.
Mueller H; Flury N; Liu R; Scheidegger S; Eppenberger U
Eur J Cancer; 1996 Dec; 32A(13):2312-8. PubMed ID: 9038615
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of interferon induction of class I major histocompatibility complex antigen expression by human tumor necrosis factor in small cell lung cancer cell lines.
Marley GM; Doyle LA; Ordóñez JV; Sisk A; Hussain A; Yen RW
Cancer Res; 1989 Nov; 49(22):6232-6. PubMed ID: 2553249
[TBL] [Abstract][Full Text] [Related]
13. In vivo effects of combination treatment with recombinant interferon-gamma and -alpha in metastatic melanoma.
Osanto S; Jansen R; Naipal AM; Gratama JW; van Leeuwen A; Cleton FJ
Int J Cancer; 1989 Jun; 43(6):1001-6. PubMed ID: 2499552
[TBL] [Abstract][Full Text] [Related]
14. Interferon-beta prevents the upregulation of interleukin-8 expression in human melanoma cells.
Singh RK; Gutman M; Llansa N; Fidler IJ
J Interferon Cytokine Res; 1996 Aug; 16(8):577-84. PubMed ID: 8877727
[TBL] [Abstract][Full Text] [Related]
15. Growth inhibition of human endothelial cells by human recombinant tumor necrosis factor alpha and interferon-gamma.
Mauerhoff T; Belfiore A; Pujol-Borrell R; Bottazzo GF
Tumori; 1994 Aug; 80(4):301-5. PubMed ID: 7974803
[TBL] [Abstract][Full Text] [Related]
16. Differential in vitro effects of recombinant alpha-interferon and recombinant gamma-interferon alone or in combination on the expression of melanoma-associated surface antigens.
Murray JL; Stuckey SE; Pillow JK; Rosenblum MG; Gutterman JU
J Biol Response Mod; 1988 Apr; 7(2):152-61. PubMed ID: 3129542
[TBL] [Abstract][Full Text] [Related]
17. Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma.
Ruggiero V; Tavernier J; Fiers W; Baglioni C
J Immunol; 1986 Apr; 136(7):2445-50. PubMed ID: 3005411
[TBL] [Abstract][Full Text] [Related]
18. Combination of tumor necrosis factor alpha and interferon alpha induces apoptotic cell death through a c-myc-dependent pathway in p53 mutant H226br non-small-cell lung cancer cell line.
Yasuoka Y; Naomoto Y; Yamatsuji T; Takaoka M; Kimura M; Uetsuka H; Matsubara N; Fujiwara T; Gunduz M; Tanaka N; Haisa M
Exp Cell Res; 2001 Dec; 271(2):214-22. PubMed ID: 11716533
[TBL] [Abstract][Full Text] [Related]
19. Differential modulation by tumor necrosis factor and immune interferon of HLA class-II antigens expressed by melanoma cells.
Maio M; Gulwani B; Morgano A; Ferrone S
Int J Cancer; 1989 Sep; 44(3):554-9. PubMed ID: 2506138
[TBL] [Abstract][Full Text] [Related]
20. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ
Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
